Clinical Trials · NCT06760546
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Enrollment
- 39
- Start date
- Sep 2025
- Locations
- 11 sites, United States, United Kingdom
- Primary endpoint
- Mean % change in BMI